USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: NERX BIOSCIENCES, INC.
City: INDIANAPOLIS
State: IN
Zip+4: 46202-4118
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,922.00 1
STTR Phase I $229,680.00 1

Award List:

Development of Novel Agents Targeting Genome Stability and Maintenance for Treati

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
Principal Investigator: John J. Turchi – 317-278-1996
Award Amount: $229,680.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Epithelial ovarian cancer (EOC) is uniformly fatal once resistance to platinum based therapy (Pt) is observed. Innate resistance is observed in approximately 25% of the nearly 22,000 annual cases of EOC, where the cancer is intrinsically refractory to Pt therapy.… More

Targeting the ERCC1/XPF nuclease for cancer therapy

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Robert Feltgen – 317-985-0330
Award Amount: $299,922.00
Abstract:
DESCRIPTION (provided by applicant): Platinum based agents (Pt) are the most commonly prescribed chemotherapeutics used in the treatment of solid tumors and are part of the curative treatment regimen for testicular cancer. While front line Pt therapy forlung cancer is often initially effective,… More